SALT LAKE CITY / Dec 01, 2024 / Business Wire / Varex Imaging Corporation (Nasdaq: VREX) is proud to introduce the LUMEN HD and LUMEN HD Pro digital radiography detectors, designed to meet the evolving standards of healthcare imaging. As the demands of medical imaging continue to shift, these detectors are built to offer reliable, fast, and user-friendly performance in today’s cost-conscious environment.
Key Features and Benefits:
As the landscape of healthcare continues to evolve, the LUMEN family is engineered to thrive in this new era. With advanced technology at their core, they meet the rigors and demands of modern imaging workflows, ensuring that healthcare providers can maintain efficiency and high standards of patient care.
For more information about the LUMEN HD and LUMEN HD Pro, please contact your Varex representative or the individuals listed below.
About Varex
Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices, and imaging software in their systems to detect, diagnose, protect, and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,300 people located in North America, Europe, and Asia. For more information visit vareximaging.com.
Forward Looking Statements
This news release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning product delivery, performance, and value; impact on the healthcare environment and workflow, as well as patient care; imaging needs; market acceptance of or transition to new products or technologies; financial results; and any statements using the terms “expect,” “can,” “could,” “may,” “intend,” “potential,” “designed,” and “possible” or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results and the outcome and timing of certain events to differ materially from those projected or management’s current expectations. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Varex assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.
Last Trade: | US$16.37 |
Daily Change: | -0.03 -0.18 |
Daily Volume: | 664,343 |
Market Cap: | US$672.810M |
March 01, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB